LPL and hypertensive disorder: As shown in Table 1, compared to the control group, PLH exhibited lower LPL levels (56.1 vs. 75.1 ng/mL, p = 0.019), lower FPG (97 vs. 107 mg/dL, p = 0.011), higher HOMA-β (66.4 vs. 49.8, p = 0.027), lower HDL-C levels (53 vs. 57 mg/dL, p = 0.021), a higher diabetes prevalence (12.1% vs. 0.0%, p = 0.039), and a lower hypertension prevalence (33.3% vs. 60.6%, p = 0.026).